232 related articles for article (PubMed ID: 30971479)
1. Development and Characterization of a Novel, High-Affinity, Specific, Radiolabeled Ligand for BRS-3 Receptors.
Ramos-Alvarez I; Lee L; Mantey SA; Jensen RT
J Pharmacol Exp Ther; 2019 Jun; 369(3):454-465. PubMed ID: 30971479
[TBL] [Abstract][Full Text] [Related]
2. Comparative pharmacology of bombesin receptor subtype-3, nonpeptide agonist MK-5046, a universal peptide agonist, and peptide antagonist Bantag-1 for human bombesin receptors.
Moreno P; Mantey SA; Nuche-Berenguer B; Reitman ML; González N; Coy DH; Jensen RT
J Pharmacol Exp Ther; 2013 Oct; 347(1):100-16. PubMed ID: 23892571
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of putative selective hBRS-3 receptor agonists for human bombesin receptors (BnR): affinities, potencies and selectivity in multiple native and BnR transfected cells.
Sancho V; Moody TW; Mantey SA; Di Florio A; Uehara H; Coy DH; Jensen RT
Peptides; 2010 Aug; 31(8):1569-78. PubMed ID: 20438784
[TBL] [Abstract][Full Text] [Related]
4. Ability of various bombesin receptor agonists and antagonists to alter intracellular signaling of the human orphan receptor BRS-3.
Ryan RR; Weber HC; Hou W; Sainz E; Mantey SA; Battey JF; Coy DH; Jensen RT
J Biol Chem; 1998 May; 273(22):13613-24. PubMed ID: 9593699
[TBL] [Abstract][Full Text] [Related]
5. Rational design of a peptide agonist that interacts selectively with the orphan receptor, bombesin receptor subtype 3.
Mantey SA; Coy DH; Pradhan TK; Igarashi H; Rizo IM; Shen L; Hou W; Hocart SJ; Jensen RT
J Biol Chem; 2001 Mar; 276(12):9219-29. PubMed ID: 11112777
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a high affinity radioligand for the human orphan receptor, bombesin receptor subtype 3, which demonstrates that it has a unique pharmacology compared with other mammalian bombesin receptors.
Mantey SA; Weber HC; Sainz E; Akeson M; Ryan RR; Pradhan TK; Searles RP; Spindel ER; Battey JF; Coy DH; Jensen RT
J Biol Chem; 1997 Oct; 272(41):26062-71. PubMed ID: 9325344
[TBL] [Abstract][Full Text] [Related]
7. Identification of a unique ligand which has high affinity for all four bombesin receptor subtypes.
Pradhan TK; Katsuno T; Taylor JE; Kim SH; Ryan RR; Mantey SA; Donohue PJ; Weber HC; Sainz E; Battey JF; Coy DH; Jensen RT
Eur J Pharmacol; 1998 Feb; 343(2-3):275-87. PubMed ID: 9570477
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis for agonist selectivity and activation of the orphan bombesin receptor subtype 3 receptor.
Gonzalez N; Hocart SJ; Portal-Nuñez S; Mantey SA; Nakagawa T; Zudaire E; Coy DH; Jensen RT
J Pharmacol Exp Ther; 2008 Feb; 324(2):463-74. PubMed ID: 18006692
[TBL] [Abstract][Full Text] [Related]
9. The Nonpeptide Agonist MK-5046 Functions As an Allosteric Agonist for the Bombesin Receptor Subtype-3.
Ramos-Alvarez I; Iordanskaia T; Mantey SA; Jensen RT
J Pharmacol Exp Ther; 2022 Aug; 382(2):66-78. PubMed ID: 35644465
[TBL] [Abstract][Full Text] [Related]
10. Development of bombesin analogs with conformationally restricted amino acid substitutions with enhanced selectivity for the orphan receptor human bombesin receptor subtype 3.
Mantey SA; Coy DH; Entsuah LK; Jensen RT
J Pharmacol Exp Ther; 2004 Sep; 310(3):1161-70. PubMed ID: 15102928
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology and intracellular signaling mechanisms of the native human orphan receptor BRS-3 in lung cancer cells.
Ryan RR; Weber HC; Mantey SA; Hou W; Hilburger ME; Pradhan TK; Coy DH; Jensen RT
J Pharmacol Exp Ther; 1998 Oct; 287(1):366-80. PubMed ID: 9765358
[TBL] [Abstract][Full Text] [Related]
12. Molecular basis for high affinity and selectivity of peptide antagonist, Bantag-1, for the orphan BB3 receptor.
Nakamura T; Ramos-Álvarez I; Iordanskaia T; Moreno P; Mantey SA; Jensen RT
Biochem Pharmacol; 2016 Sep; 115():64-76. PubMed ID: 27346274
[TBL] [Abstract][Full Text] [Related]
13. Pharmacology and selectivity of various natural and synthetic bombesin related peptide agonists for human and rat bombesin receptors differs.
Uehara H; González N; Sancho V; Mantey SA; Nuche-Berenguer B; Pradhan T; Coy DH; Jensen RT
Peptides; 2011 Aug; 32(8):1685-99. PubMed ID: 21729729
[TBL] [Abstract][Full Text] [Related]
14. Identification of key amino acids in the gastrin-releasing peptide receptor (GRPR) responsible for high affinity binding of gastrin-releasing peptide (GRP).
Nakagawa T; Hocart SJ; Schumann M; Tapia JA; Mantey SA; Coy DH; Tokita K; Katsuno T; Jensen RT
Biochem Pharmacol; 2005 Feb; 69(4):579-93. PubMed ID: 15670577
[TBL] [Abstract][Full Text] [Related]
15. A possible new target in lung-cancer cells: The orphan receptor, bombesin receptor subtype-3.
Moreno P; Mantey SA; Lee SH; Ramos-Álvarez I; Moody TW; Jensen RT
Peptides; 2018 Mar; 101():213-226. PubMed ID: 29410320
[TBL] [Abstract][Full Text] [Related]
16. Discovery of high affinity bombesin receptor subtype 3 agonists.
Wu JM; Nitecki DE; Biancalana S; Feldman RI
Mol Pharmacol; 1996 Nov; 50(5):1355-63. PubMed ID: 8913368
[TBL] [Abstract][Full Text] [Related]
17. Characterization of bombesin receptors using a novel, potent, radiolabeled antagonist that distinguishes bombesin receptor subtypes.
Mantey S; Frucht H; Coy DH; Jensen RT
Mol Pharmacol; 1993 May; 43(5):762-74. PubMed ID: 7684815
[TBL] [Abstract][Full Text] [Related]
18. The presence of receptors for bombesin/GRP and mRNA for three receptor subtypes in human ovarian epithelial cancers.
Sun B; Schally AV; Halmos G
Regul Pept; 2000 Jun; 90(1-3):77-84. PubMed ID: 10828496
[TBL] [Abstract][Full Text] [Related]
19. Identification of bombesin receptor subtype-specific ligands: effect of N-methyl scanning, truncation, substitution, and evaluation of putative reported selective ligands.
Mantey SA; Gonzalez N; Schumann M; Pradhan TK; Shen L; Coy DH; Jensen RT
J Pharmacol Exp Ther; 2006 Nov; 319(2):980-9. PubMed ID: 16943256
[TBL] [Abstract][Full Text] [Related]
20. Biology and pharmacology of bombesin receptor subtype-3.
Majumdar ID; Weber HC
Curr Opin Endocrinol Diabetes Obes; 2012 Feb; 19(1):3-7. PubMed ID: 22157398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
